drugset / Trial / NCT00900783
A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the safety and efficacy of two doses of FV-100 to valacyclovir in patients with herpes zoster, or shingles. FV-100 has shown to be very potent in cells infected with varicella zoster virus, the virus that causes shingles. The study objectives include: * Compare the safety of FV-100 to valacyclovir * Compare the effect of FV-100, as compared to valacyclovir, on shingles pain * Compare the effect of FV-100, as compared to valacyclovir, on shingles lesions
Timeline
- Start
- 2009-05
- Primary completion
- 2010-11
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VALNIVUDINE | Small molecule | 200 mg | — |
| Subject | VALNIVUDINE | Small molecule | 400 mg | — |
| Comparator | Valacyclovir | Unknown | 1 g | — |